ONEMEDNET CORPORATION Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
ONEMEDNET CORPORATION (ONMD) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 64.04 thousand shares for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2026-08-14
- ONEMEDNET CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-06-30 was 33.78K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month |
|---|---|---|---|
| 2025-09-30 | 64.04K shares 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | 33.78K shares 10-Q · filed 2026-08-14 | 60.12K shares 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |